Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Epoetin beta may stimulate red blood cell production to prevent or control anemia
in patients treated with chemotherapy and radiation therapy.
PURPOSE: Randomized phase IV trial to determine the effectiveness of epoetin beta in treating
anemia in patients who are receiving cisplatin and radiation therapy for stage IIB, stage
III, or stage IVA cervical cancer.